Free Essay

Sovaldi

In:

Submitted By mehdibaig
Words 650
Pages 3
Sovaldi With hepatitis C drug sales rising since 2014 by generating $5.7 billion in sales according to an earnings report from Gilead Sciences, consumers have pinpointed Sovaldi as source for the affluent growth (Tozzi, pg 1). Sovaldi, manufactured by Gilead Pharmaceuticals, is a revolutionary drug that has alienated itself from its competitors by curing around 90% of patients with Hepatitis C instead of resolving its symptoms, which until now was the only solution. (Mukhergee, pg 3) Although this deserves much praise and merit for a scientific breakthrough, consumers such as insurance companies and state Medicaid programs are raising other issues. This drug is priced at an eye opening $84,000 for a 12-week treatment, or $1,000 per pill, and has successfully cured 9,000 patients suffering from Hepatitis C following this treatment, according to Gilead (CSRP, pg 2). Across the Pacific, the same treatment is being offered to patients in India for 1% of the price sold in the USA. This raises many questions economically and scientifically since there is still ongoing research of its effectiveness; however, the burning question that needs to be addressed today in order to provide my recommendation for Sovaldi is how the benefits outweigh the cost in the long run.
An estimated 3.2 million people suffer in the USA from Hepatitis C and that number is still expanding (Sanger-Katz, pg 1). When performing scientific studies, we have learned that in order to evaluate the efficacy of a substance, you have to remove it from the equation first and examine the outcome. Without Sovaldi on the market, millions of patients are forced to rely on other treatments that only tackle the symptoms of Hepatitis C, leaving the root of the problem unresolved. Over time, 60 percent of these people will end up with chronic liver disease and as many as 20 percent will end up with cirrhosis along with over complications such as joint pain and kidney disease(Mukherjee, pg 3). In addition, a small group of patients may require a liver transplant who are diagnosed with end-stage disease costing nearly $600,000 (Mukherjee, pg 3). In juxtaposition, that is 86 percent more expensive, not including the cost of medications and follow-up care required to live with the disease. There is an undeniable risk associated with providing Sovaldi and overpaying for its benefits. However, by removing Sovaldi as a possible treatment option, the financial burden of treating Hepatitis C still exists coupled with an emotional one for patients who would have to continue living with it.
Sovaldi is like buying a house with cash up front versus allowing the costs to pile up slowly over time. Consumers do not understand that Hepatitis C treatment options currently have compounding effect. In comparison to HIV, the lifetime cost of treating someone is around $380,000, according to estimates from CDC, which is not alarming to other critics (Sanger-katz, pg 1). $84,000 for a one time treatment is a reasonable option for patients. Dissecting it further down the timeline, we are in a volatile competitive market. The price of $1,000 per pill will not exist ten years later especially after the eventual emergence of a generic brand. A company’s IPO is not equivalent to its EPS a few years after production. The high cost initially for the drug will change and can only decrease in the future.
Today, I would like to recommend Sovaldi as it will welcome more subscribers towards Kaiser, particularly those with a higher income that can afford the treatment. Overtime, it will generate revenue for Gilead and lower the cost of Sovaldi. It will promote the importance of health worldwide by making this decision. Most importantly, the fatality rate will decrease substantially making happier and healthier patients. Kaiser Permanente will become the health care provider that sets the tone for other providers to follow.

Similar Documents

Free Essay

Biotech

...is in the early innings of an innovation cycle with many labelexpansion opportunities and novel agents in phase 2 or 3 trials that are largely unaccounted for in Street models. Hence, we are bullish on the group for 2014. Please join us for a call today at 11am ET to discuss our sector outlook/favorite names (US dial-in: 888-889-1309; OUS: 773-756-0161; Passcode: BIOTECH).  Large-cap biotech: We don’t believe that a strict assessment of P/E multiples accurately addresses the nuances of the sector (2014e – Biotech: 22x vs. S&P 500: 15x). In our view, large caps are poised for an inflection point in revenue growth over the next two years, driven by significant drug launches in major therapeutic categories. Some of these include Gilead’s Sovaldi in hep C, Biogen’s...

Words: 13041 - Pages: 53

Premium Essay

Hepatitis C Research Paper

...Interferon drugs (a protein used in immune to virus reproduction intervenes) such as Pegasys and Pegintron. Protein protease blocker (protease inhibitor) that interfere with the replication of the virus such as: Sofosbuvir (Sovaldi), Olysio (Simeprevir), Victrelis (Boceprevir) and Incivek (Telaprevir). As well as polymerase inhibitor drugs such as Exviera (Dasabuvir). Unlike the previous generation hepatitis C drug that is done by injection into the patient once a week, now patients only need to take one pill every day for 3-6 months depending on the patient's heart condition and types of the virus. A cure rate of these medicines is also quite high at 98-100 percent. Sofosbuvir administration period is 12 to 24 weeks at a dose of 400 milligrams per day. The side effects is fairly mild, such as insomnia, anemia, headache, and vomiting. Taking care of...

Words: 380 - Pages: 2

Premium Essay

Anti-Cancer Drug Cost Regulations- Cocontainment for the Pharmaceutical Companies

...Anti-Cancer Drug Cost Regulations- Cost-Containment for the Pharmaceutical Companies Brenda Roberson University of Maryland University College Abstract Drug development is a long, inefficient, and expensive process and takes 10 to 15 years for development at a cost of about $1.3 billion (Nelson, 2014). When speaking of research and development (R&D) for new drugs; a large number of drugs that go through research do not make it to the FDA or the marketplace. Critics of pharmaceutical companies point out that only a small portion of the pharmaceutical companies’ expenditures account for research and development (R&D). The majority of the money’s spent in marketing and administration. There is also controversy over the $1.3 billion figure as an actual cost. Reported by Nelson (2014) Dr. Kantarjian of M.D. Anderson disputes the $1.3 billion figure for development; he believes this figure to be inflated to cover ancillary expenses, salaries, bonuses, stock market returns, and other indirect costs not related to R&D. The cost of cancer drug therapy is becoming impossible to justify or rationalize for both patient and society. New cancer drugs being approved by the Food and Drug Administration (FDA) are typically costing upwards of $100,000 per year and many times used in combination with other agents (Bunnell, 2012, p. 932) increasing the cost even more. These high priced anti-cancer drugs achieve only marginal benefit for the patient. Benefits achievements of...

Words: 2794 - Pages: 12

Premium Essay

Economics

...Key Issues & Economic Pressures Impacting the Pharmaceutical Industry in 2015 Presented to: Dr. Siamack Shojai Economic Analysis 6090, William Paterson University December 15th, 2015 The pharmaceutical industry has experienced tremendous growth over the past few decades, with a substantial change in the market dynamic from a provider, healthcare plan & patient perspective. Medical advancements coupled with research & development efforts have expanded the product base in terms of a variety of new treatments across numerous therapeutic classes. As depicted in the illustration below, the total global pharmaceutical sales reached $1,057,000,000 in 2014; based on the past 10 years we can expect the forecast to show a similar increase over the next few years. IMS Health Market Prognosis, May 2015 Of all the changes visible within the pharmaceutical market, there are a few that are truly revolutionizing the market: US healthcare reform, emergence of specialty product markets, price strategy & mergers & acquisitions. The healthcare market has changed under Obama, opening healthcare coverage to more patients & bringing forth treatment & medication to a larger population. The emergence of specialty products pose an entirely new challenge to the market in terms of the doctor’s prescribing habits, healthcare plan coverage & out-of-pocket cost to the patient. This along with other economic pressures brings an entirely new perspective to pharmaceutical...

Words: 3963 - Pages: 16

Premium Essay

Health Care Deli

...‘ Health Care Delivery Systems Issue Report: Cost of Prescription Medications Jill Stanley Seattle Pacific University Health Care Delivery Models NUR 4944 July 19, 2014 Most everyone knows that the United States has the leading role when it comes to health care spending and pays out almost one thousand dollars per person per year on pharmaceuticals (Paris, 2014). Sadly, while the financial burden is high for the average family, many Americans are not taking their recommended medications because of the high costs. One in five Americans skip doses because of the cost (Paris, 2014). While there are many things nurses can do to enhance prescription medication compliance, understanding costs and helping implement ways in which patients can control costs, while promoting better outcomes, is critical. The United States spends almost 800 dollars a unit per population on prescription drugs, more than any other country and almost twice the average of 401 dollars per capita (OECD), (Ginsburg et al., 2009, p. 28). Prescriptions account for 17% of all privately insured health care costs and 25.4% of out of pocket spending according to Health Care Cost and Utilization Report (HCCI): 2011. Brand name or patented drugs have increased in price by 17.7% from 2010 to 2011 and generic drugs have actually decreased in cost by -7.2% for the same years from the same HCCI report. Generic drugs have had an increase in utilization from consumers’ while brand name has decreased and this...

Words: 2836 - Pages: 12

Premium Essay

Hepatitis C Case Study

...of testing and interpretation of results. o Information about medical management and long-term care: < How to select candidates for antiviral therapy. < Importance of liver-cancer screening. < When to refer patients to a specialist.” The strategy of educational programs of Hep C should be used globally to reduce the risk of spreading the virus and to prevent further infections by treating all that are infected with HCV. Early treatment of Hep C saves the expensive complications of the future such as cirrhosis, liver transplant, or liver cancer. Treatment Hep C has over 90 percent cure rate, however the newer medication is very costly. The pharmaceutical company Gilead Sciences Inc. of Foster City, California produces it. “The new drug Sovaldi costs $1,000 per pill. A typical course of treatment will last 12 weeks and run $84,000, plus the cost of necessary companion drugs. Some patients may need treatment for twice as long.” The cost is out of reach for most that are infected and not all of the insurance companies cover the medication. The Hepatitis Foundation International (HFI) is a leading organization working for access to treatment for millions. “The Hepatitis Foundation International (HFI) is a 501 (c) 3 non-profit organization established in 1994 with world headquarters located in Silver Spring, MD. Since its inception, HFI has worked on eradicating chronic hepatitis by promoting and advocating for health and wellness.” HFI’s mission is to educate, prevent, support...

Words: 1639 - Pages: 7

Free Essay

Current Affairs

...Inclusive Learning Guaranteed!!! (LIKE US ON FACEBOOK AND GET ALL IMPORTANT UPDATES) Category Wise Current Affairs from January 2015 to June 2015 1) Awards and Honours 2) Appointments 3) Banking and Finance 4) Indian Affairs 5) International Affairs 6) Science and Technology 7) Sports 8) Obituary Visit DayTodayGK.com for Current Affairs, General Knowledge, Current Affairs Quiz, Banking Quiz, Marketing Quiz, Science Quiz, English Quiz..etc 9) Important days observed from January to June THE MORE YOU VISIT THE MORE YOU SUCCEED All the Success for your upcoming Exams!!! Contact us at arunsathyan.day2daygk@gmail.com & prerikagupta.day2daygk@gmail.com (Feedbacks are Greatly Appreciated) Do It Now. Sometimes Later Becomes Never. Current Affairs Jan to June AWARDS AND HONOURS Name of the Award Business Person of the Year State Pre-Eminent Science and Technology Award 2015 Space Pioneer Award Award Winner Larry Page Yu Min – Nuclear Scientist ISRO’s Mars Orbiter Mission (MOM) Team Asian Tour’s Players Player of Anirban Lahiri the Year Ballon d’Or 2014 Award Cristiano Ronaldo Governor of the Year Raghuram Rajan National e-Governance Award Vyas Samman Award 2014 Jammu and Kashmir National Tiger Conservation Authority Award Vikram Sarabhai Memorial Award Sahitya Akademi Award Periyar Tiger Reserve NSC Award for Best Electoral Practices Social Media Person of the year 2015 Giraffe Hero Award Best Indian Language Website in India Hindu Literary Prize 2014 CV Anand Martin Luther...

Words: 30993 - Pages: 124

Free Essay

Gggg

...Page No. 2 Index Swachh Bharat Mission FEB & MARCH, 2015 AUGUST, 2012 Page No. 4 Insurance Sector In India Page No. 5 Bharat Ratna Award Designed by: Chandan Kumar “Raja” For Advertisement Contact at : 9958790414 Join us at Facebook: https://www.facebook.com/iasexamportal Follow us at Twitter: https://twitter.com/iasexamportal CURRENT AFFAIRS National Issues International Issues India & the World Economy Science and Technology Sports Awards & Prizes In The News 6 14 20 23 39 51 58 64 Disclaimer: Editor and Publisher are not responsible for any view, data, figure etc. expressed in the articles by the author(s). Maps are notational . All Disputes are subject to the exclusive jurisdiction of competent courts and fourms in Delhi/New Delhi only. Selected Articles from Various Newspapers & Journals Page No. 67 91 Cyberspace Page No. 93 Regional Rural Banks The Mauryan Empire Model Paper G.S. Paper I 94 117 Join Online Coaching For IAS Pre & Mains Exams http://iasexamportal.com/civilservices/courses Project Mausam and Maritime Silk Route SWACHH BHARAT MISSION Throughout the world around 2.5 billion people do not have toilets to use, out of those 250 crore people 65 crore live in India alone. In order to solve this big challenge government of India has launched “Swachh Bharat Mission” on the birth anniversary of Mahatma Gandhi and former Prime Minister Lal Bahadur Shastri...

Words: 80076 - Pages: 321